Clinical Trials Logo

Histological Response clinical trials

View clinical trials related to Histological Response.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03358992 Recruiting - Survival Clinical Trials

Clinical Evaluation for Sarcoma Originated From Bone

CESOFB
Start date: January 1, 2018
Phase:
Study type: Observational

Response Evaluation Criteria in Solid Tumors (RECIST) are insensitive in evaluating primary sarcoma originated from bone treated with chemotherapy or targeted therapy, which did not have the definition of measurement methods either. This study evaluates whether clinical imaging findings of sarcoma after preoperative chemotherapy correlate with tumor responses by pathological evaluation by Huvos classifications and develops reliable, quantitative, clinical response criteria.